Management of late recurrence of a low-grade endometrial stromal sarcoma (LGESS): Treatment with letrozole

Anticancer Research

Volumn 27, Issue 5 B, 2007, Pages 3477-3480

  Krauss, K ^a   Bachmann, C ^a   Hartmann, J T ^a,b   Siegmann, K ^a   Sotlar, K ^c   Wallwiener, D ^a   Huober, J ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Hematol Oncol and Transfus Med   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

ESS; Letrozole; LGESS; Low grade endometrial stromal sarcoma; Recurrence; Uterine sarcoma

Indexed keywords

AMINOGLUTETHIMIDE; AROMATASE INHIBITOR; BISPHOSPHONIC ACID DERIVATIVE; CYTOTOXIC AGENT; LETROZOLE; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE;

ADULT; ANAMNESIS; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ENDOMETRIUM SARCOMA; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; PRIORITY JOURNAL; RADIATION DOSE; SALPINGOOOPHORECTOMY; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; ANTINEOPLASTIC AGENTS; ENDOMETRIAL STROMAL TUMORS; FEMALE; HUMANS; MUSCLE NEOPLASMS; NITRILES; PSOAS MUSCLES; RADIOGRAPHY, ABDOMINAL; RECURRENCE; TOMOGRAPHY, X-RAY COMPUTED; TRIAZOLES;

EID: 35348987619     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Hendrickson MR, Tavassoli FA, Kempson RL, McCluggage WG, Haller U and Kubick-Huch RA: Tumors of the uterine corpus: mesenchymal tumors and related lesions, In: WHO Classification of Tumors: Tumors of the Breast and Female Genital Organs. Tavassoli FA and Devilee P (eds). IARC Press, Lyon, France, pp. 233-244, 2003.
2. Coindre JM: Recommendations for anatamo-pathologic management of soft tissue sarcomas in the adult. Pathologists of the FNCLCC Sarcoma Group (Federation Nationale des Centres de Lutte Contre le Cancer). Ann Pathol 18: 505-511, 1998.
3. Weitmann HD, Knocke TH, Kucera H and Potter R: Radiation therapy in the treatment of endometrial stromal sarcoma. Int J Radiat Oncol Biol Phys 49: 739-748, 2001.
4. Bodner K, Bodner-Adler B, Obermair A, Windbichler G, Petru E, Mayerhofer S, Czerwenka K, Leodolter S, Kainz C and Mayerhofer K: Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients. Gynecol Oncol 81: 160-165, 2001.
5. Haberal A, Kayikcioglu F, Boran N, Caliskan E, Ozgul N and Kose MF: Endometrial stromal sarcoma of the uterus: analysis of 25 patients. Eur J Obstet Gynecol Reprod Biol 109: 209-213, 2003.
6. Sabini G, Chumas JC and Mann WJ: Steroid hormone receptors in endometrial stromal sarcomas. A biochemical and immunohistochemical study. Am J Clin Pathol 97: 381-386, 1992.
7. Chu MC, Mor G, Lim C, Zheng W, Parkash V and Schwartz PE: Low-grade endometrial stromal sarcoma: hormonal aspects. Gynecol Oncol 90: 170-176, 2003.
8. Schwartz SM and Thomas DB: A case control study of risk factors for sarcomas of the uterus. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Cancer 64: 2487-2492, 1989.
9. Pink D, Lindner T, Mrozek A, Kretzschmar A, Thuss-Patience PC, Dorken B and Reichardt P: Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature. Gynecol Oncol 101: 464-469, 2006.
10. Spano JP, Soria JC, Kambouchner M, Piperno-Neuman S, Morin F, Morere JF, Martin A and Breau JL: Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma. Med Oncol 20: 87-93, 2003.
11. Maluf FC, Sabbatini P, Schwartz L, Xia J and Aghajanian C: Endometrial stromal sarcoma: objective response to letrozole. Gynecol Oncol 82: 384-388, 2001.
12. Leunen M, Breugelmans M, De Sutter P, Bourgain C and Amy JJ: Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole. Gynecol Oncol 95: 769-771, 2004.